Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 370345, 5 pages
http://dx.doi.org/10.4061/2011/370345
Review Article

Copper Modulation as a Therapy for Alzheimer's Disease?

1Institute of Neurosciences and Department of Cellular Biology, Physiology and Immunology, Faculty of Biosciences, Autonomous University of Barcelona, Bellaterra, 08193 Barcelona, Spain
2Oxidation Biology Laboratory, The Mental Health Research Institute, Parkville, Vic 3052, Australia
3Synaptic Neurobiology Laboratory, The Mental Health Research Institute, Parkville, Vic 3052, Australia
4Department of Pathology, The University of Melbourne, Parkville, Vic 3010, Australia

Received 24 May 2011; Accepted 30 June 2011

Academic Editor: Rosanna Squitti

Copyright © 2011 Yasmina Manso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Maria C. Linder, “The relationship of copper to DNA damage and damage prevention in humans,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 733, no. 1-2, pp. 83–91, 2012. View at Publisher · View at Google Scholar
  • Kimberly M. Lincoln, Timothy E. Richardson, Lauren Rutter, Paulina Gonzalez, James W. Simpkins, and Kayla N. Green, “An N-Heterocyclic Amine Chelate Capable of Antioxidant Capacity and Amyloid Disaggregation,” ACS Chemical Neuroscience, vol. 3, no. 11, pp. 919–927, 2012. View at Publisher · View at Google Scholar
  • Pascale Delangle, and Elisabeth Mintz, “Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators,” Dalton Transactions, vol. 41, no. 21, pp. 6359–6370, 2012. View at Publisher · View at Google Scholar
  • Morteza Azhdarzadeh, Maryam Noroozian, Haniyeh Aghaverdi, Seyed Mostafa Akbari, Larry Baum, and Morteza Mahmoudi, “Serum Multivalent Cationic Pattern: Speculation on the Efficient Approach for Detection of Alzheimer's Disease,” Scientific Reports, vol. 3, 2013. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andrea Pfeifer, and Andreas Muhs, “Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs,” Journal Of Alzheimers Disease, vol. 34, no. 1, pp. 1–114, 2013. View at Publisher · View at Google Scholar
  • Hyuck Jin Lee, Kyle J. Korshavn, Akiko Kochi, Jeffrey S. Derrick, and Mi Hee Lim, “Cholesterol and metal ions in Alzheimer's disease,” Chemical Society Reviews, vol. 43, no. 19, pp. 6672–6682, 2014. View at Publisher · View at Google Scholar
  • Ziwei Chen, Giulia Nesi, Marco Macchia, Simona Rapposelli, Rongbiao Pi, Maria Digiacomo, Yalin Tu, Qiong Gu, Xiaohong Yang, Jiaqi Chu, Qiuhe Chen, Yifan Han, Jingkao Chen, Simona Sestito, and Shengnan Wang, “Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease,” European Journal of Medicinal Chemistry, vol. 125, pp. 784–792, 2017. View at Publisher · View at Google Scholar
  • Myrna Hurtado, Umesh T. Sankpal, Jaya Chhabra, Deondra T. Brown, Rajasekhar Maram, Rafid Patel, Raj K. Gurung, Jerry Simecka, Alvin A. Holder, and Riyaz Basha, “Copper-tolfenamic acid: evaluation of stability and anti-cancer activity,” Investigational New Drugs, 2018. View at Publisher · View at Google Scholar